SAN DIEGO – As the window for companies going public has swung wide open and values across the industry have risen, it’s becoming harder for companies to get deals done. Read More
One of the opportunities for biotechnology companies seeing their shares soar is that they can find a welcoming market for their follow-on financings. No surprise then that since the beginning of the year these transactions have been in high gear and more than $2.7 billion has been raised already. Read More
